Clinical efficacy, predictive biomarkers and response patterns of immunotherapy combinations for patients with cancer

Future Oncol. 2020 Aug;16(23):1659-1664. doi: 10.2217/fon-2020-0707.

Authors

Gonzalo Recondo¹, Laura Mezquita²

Affiliations

¹ Thoracic Unit, Medical Oncology, Center for Medical Education & Clinical Research (CEMIC), C1431FWO, Buenos Aires, Argentina.
² Thoracic Unit, Medical Oncology Department, Hospital Clinic, 08036, Barcelona, Spain.

PMID: 32783513
DOI: 10.2217/fon-2020-0707

No abstract available

Keywords: cancer; combination; immunotherapy.

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers, Tumor / metabolism*
Humans
Immunotherapy*
Molecular Targeted Therapy*
Neoplasms / drug therapy*
Neoplasms / immunology
Neoplasms / metabolism
Treatment Outcome

Substances

Biomarkers, Tumor